LogicBio Therapeutics, Inc. is a genome editing company, which engages in developing medicines to treat rare diseases in patients with significant unmet medical need. It focuses on the commercialization of specific genome editing and integration of the therapeutic transgene. The company was founded by Mark A. Kay, Leszek Lisowski, and Adi Barzel in August 2014 and is headquartered in Cambridge, MA.
![LOGIC DEVICES logo](/files/LOGO/802851-LOGC.png)
Company profile
Website
CEO
Frédéric Chéreau
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
LOGIC DEVICES INC
SEC CIK
Corporate docs
IRS number
942893789
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
17 Oct 16
NT 10-K
Notice of late annual filing
31 Dec 12
10-Q
2012 Q3
Quarterly report
14 Aug 12
10-Q
2012 Q2
Quarterly report
21 May 12
NT 10-Q
Notice of late quarterly filing
15 May 12
10-Q
2012 Q1
Quarterly report
16 Feb 12
NT 10-Q
Notice of late quarterly filing
15 Feb 12
DEF 14A
Definitive proxy
14 Feb 12
Latest ownership filings
No filings